Unknown

Dataset Information

0

Predicting β-lactam resistance using whole genome sequencing in Klebsiella pneumoniae: the challenge of β-lactamase inhibitors.


ABSTRACT: Although multiple antimicrobial resistance (AMR) determinants can confer the same in vitro antimicrobial susceptibility testing (AST) phenotype, their differing effect on optimal therapeutic choices is uncertain. Using a large population-based collection of clinical strains spanning a 3.5-year period, we applied WGS to detect inhibitor resistant (IR), extended-spectrum β-lactamase (ESBL), and carbapenem resistant (CR) β-lactamase (bla) genes and compared the genotype to the AST phenotype in select isolates. All blaNDM-1 (9/9) and the majority of blaNDM-1/OXA-48 (3/4) containing isolates were resistant to CAZ/AVI as predicted by WGS. The combination of ATM and CAZ/AVI restored susceptibility by disk diffusion assay. Unexpectedly, clinical Kp isolates bearing blaKPC-8 (V240G) and blaKPC-14 (G242 and T243 deletion) did not test fully resistant to CAZ/AVI. Lastly, despite the complexity of the β-lactamase background, CAZ/AVI retained potency. Presumed phenotypes conferred by AMR determinants need to be tested if therapeutic decisions are being guided by their presence or absence.

SUBMITTER: Hujer AM 

PROVIDER: S-EPMC8519184 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10480165 | biostudies-literature
| S-EPMC6692064 | biostudies-literature
| S-EPMC1147891 | biostudies-other
| S-EPMC7650633 | biostudies-literature
| S-EPMC6472517 | biostudies-literature
| S-EPMC8627661 | biostudies-literature
| S-EPMC10215138 | biostudies-literature
| S-EPMC4414382 | biostudies-literature
| S-EPMC5541162 | biostudies-literature
| S-EPMC4806972 | biostudies-literature